ReviewCritical care (London, England)2007
Clinical review: update of avian influenza A infections in humans.
Review in Critical care (London, England), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.
- Guidelines on management of human infection with the novel virus influenza A (H1N1)--a report from the Hospital das Clínicas of the University of São Paulo.Clinics (Sao Paulo, Brazil) · 2009Guideline
- Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus.Viruses · 2023Review
- CRISPR/Cas13a combined with hybridization chain reaction for visual detection of influenza A (H1N1) virus.Analytical and bioanalytical chemistry · 2022Article
- Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use.Clinical and experimental vaccine research · 2014Review
- Rapid and quantitative detection of zoonotic influenza A virus infection utilizing coumarin-derived dendrimer-based fluorescent immunochromatographic strip test (FICT).Theranostics · 2014Article
- Hemagglutinin from the H5N1 virus activates Janus kinase 3 to dysregulate innate immunity.PloS one · 2012Article
- Swine Influenza (H1N1) pneumonia: clinical considerations.Infectious disease clinics of North America · 2010Review
- Taipei's use of a multi-channel mass risk communication program to rapidly reverse an epidemic of highly communicable disease.PloS one · 2009Article
- Respiratory infections unique to Asia.Respirology (Carlton, Vic.) · 2008Review
- Role of hypercytokinemia in NF-kappaB p50-deficient mice after H5N1 influenza A virus infection.Journal of virology · 2008Article
- Risk for avian influenza virus exposure at human-wildlife interface.Emerging infectious diseases · 2008Article
- [Five years of the Robert Koch Institute guidelines for reprocessing of flexible endoscopes. A look back and a look forward].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2008Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza A viruses have a wide host range for infection, from wild waterfowl to poultry to humans. Recently, the cross-species transmission of avian influenza A, particularly subtype H5N1, has highlighted the importance of the non-human subtypes and their incidence in the human population has increased over the past decade. During cross-species transmission, human disease can range from the asymptomatic to mild conjunctivitis to fulminant pneumonia and death. With these cases, however, the risk for genetic change and development of a novel virus increases, heightening the need for public health and hospital measures. This review discusses the epidemiology, host range, human disease, outcome, treatment, and prevention of cross-transmission of avian influenza A into humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.